Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Niagen Bioscience heads into the week with one of the most striking options sentiment reversals in the past year — call buyers have overwhelmed the market with an aggression that places the current read near the year's…
Energy Recovery filed Q1 results on May 6 against a backdrop of significant management upheaval — the real story here is not the mixed earnings print but what the departure of the CEO and CFO signals about the period…
Intrepid Potash heads into the aftermath of its Q1 earnings beat with short sellers caught on the wrong side of a 7% weekly rally. The results landed after the close on May 6. Adjusted EPS came in at $0.62 against a…
Clearfield, Inc. just reported Q2 FY2026 results after the bell on May 6, making this an earnings-driven setup — and the short interest data heading into the print tells a notably charged story. The clearest signal in…
MSCI heads into the back half of May with the Street's conviction rising but the stock trading roughly 15% below the average analyst target — a gap that frames the week's interesting tension. The most notable story…
Kratos Defense & Security Solutions enters post-earnings trade with a story that should be straightforward — a Q1 beat and a full-year guidance raise — yet the stock is down 12% over the past month and lost another…
GPRK heads into post-earnings trading with one of the more interesting confluences in the Latin American E&P space: a clean earnings beat delivered just as the stock crossed its 50-day moving average, borrow…
Accuray reported Q3 fiscal 2026 results on May 6 that landed squarely on the wrong side of expectations — and the company went further, pulling its full-year guidance entirely. The headline numbers told the story…
LifeVantage Corporation enters the week in a rare position: the stock is up 29% over the past month yet short sellers are still sitting on one of the heaviest positions in the entire market. That contradiction —…
EHTH just reported Q1 2026 results after the close on May 6, and the setup heading into the print was more interesting than the stock's $1.97 price suggests. The most compelling data point of recent weeks is not on the…
Owens Corning enters the week after earnings on a strong note. The stock jumped 5.1% on May 5 to close at $122.90. Yet beneath the relief rally, short sellers have been quietly rebuilding positions — and options…
Compass Diversified heads into its Q1 results — reported after the close on May 6 — carrying one of the stranger setups of the week: a CFO who bought the stock at $8.50 in early April and is sitting on a 37% gain, a…
Vanda Pharmaceuticals enters the post-Q1 stretch having just delivered a messy earnings print — but with a guidance raise that gives the bulls something to work with. The company reported Q1 EPS of -$0.82, missing the…
Brookdale Senior Living just reported Q1 2026 results, and the print gives the market something to chew on: EPS of -$0.03 came in line with expectations, but revenue of $764.9 million missed the consensus estimate of…
CF Industries reports Q1 2026 results on May 7, with the stock at $128.04 — right on top of analyst consensus — and a fleet of target increases that hasn't yet convinced the Street to upgrade its ratings. The analyst…
Galapagos NV dropped its Q1 2026 results after market close on May 6, delivering a split verdict that keeps the debate around this Belgian biotech very much alive. The headline read was mixed. Q1 EPS came in at $0.25,…
Alto Ingredients heads into its May 7 earnings report on a remarkable run — up 28% in a month and 13% on the week — yet the company's entire executive team sold shares just five weeks ago. The insider activity is the…
Herbalife enters a fresh week with a notable contradiction: the stock is up 17% over the past month, yet a cluster of insiders just rang the register at the top. The insider story is the sharpest angle this week. On…
Ormat Technologies walks into its Q1 2026 results — scheduled for May 7 — with a quietly charged setup. Short interest has risen steadily all month, options traders have turned more cautious than usual, and the stock…
Innoviva reported Q1 2026 results after the close on May 6, posting a massive EPS beat — $2.22 actual against a $0.36 consensus estimate — while revenue of $97.99 million came in slightly short of the $101.56 million…
